Citation: J. Erbey et K. Williams, WEIGHT-GAIN, GLYCEMIC CONTROL AND CARDIOVASCULAR RISK-FACTORS IN A TYPE-1 DIABETES POPULATION, Diabetes, 47, 1998, pp. 44-44
Citation: D. Ellis et al., URINARY MEASUREMENT OF TRANSFORMING-GROWTH-FACTOR-BETA AND TYPE-IV COLLAGEN AS NEW MARKERS OF RENAL INJURY - APPLICATION IN DIABETIC NEPHROPATHY, Clinical chemistry, 44(5), 1998, pp. 950-956
Citation: J. Zgibor et J. Erbey, ARE CALCIUM-CHANNEL BLOCKERS ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH IDDM, Diabetes, 46, 1997, pp. 379-379
Citation: J. Erbey et al., LOW-BIRTH-WEIGHT (BW) AND EARLY DEVELOPMENT OF MICROALBUMINURIA (MA) IN INSULIN-DEPENDENT DIABETES, Diabetes, 46, 1997, pp. 474-474
Citation: J. Erbey et G. Pambianco, PREDICTIVE POWER OF THE INSULIN-RESISTANCE SYNDROME MARKERS ON CARDIOVASCULAR-DISEASE, Diabetes, 45, 1996, pp. 1039-1039
Citation: R. Suminski et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BYCOMPLICATIONS, Diabetes, 43, 1994, pp. 10000197-10000197